glp-1 in europe The era is here. From obesity treatment to metabolic health innovation, GLP-1 therapies are changing the future of healthcare 🌍 As an Official Partner at HLTH 2026, @coherent_market_insights is bringing GLP-1 Receptor Agonist Market to

Facial cream containing GHK-Cu and melatonin increased collagen in photoaged skin of 20 female volunteers, performing better than vitamin C and retinoic acid

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in people taking the powerful medications

10.1038/s42255-020-0171-3 126 Sanchez-GarridoM

Main Indications : peripheral circulatory disorders, cardiovascular support as a medical complement, heavy legs (with other active ingredients)